CRMD · NASDAQ · Biotechnology

CorMedix (CRMD)

Sells an FDA-approved catheter lock solution and a portfolio of hospital anti-infective drugs across the US.

$7.64
vs last close−0.14 (−1.75%)
  1. CorMedix (CRMD) Upgraded to Buy: Here's Why

    Zacks Investment ResearchPrice target